Skip to content

The Role of Long Non-coding RNAs WRAP53 and UCA-1 as Potential Biomarkers in Diagnosis of Hepatocellular Carcinoma

The Role of Long Non-coding RNAs WRAP53 and UCA-1 as Potential Biomarkers in Diagnosis of Hepatocellular Carcinoma

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05088811
Enrollment
80
Registered
2021-10-22
Start date
2021-08-21
Completion date
2022-09-30
Last updated
2021-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnoses Disease, Hepatocellular Carcinoma, Liver Cirrhosis

Keywords

Hcc, liver cirrhosis, UCA-1, WRAP53

Brief summary

The aim of this work is to study the role of long non-coding RNAs WRAP53 and urothelial carcinoma-associated 1 (UCA1) as potential biomarkers in diagnosis of hepatocellular carcinoma.

Detailed description

Sample size calculation was done in department of medical statistics, Medical Research Institute, Alexandria University and the total minimal sample size was calculated. A prospective case control study will be conducted on 80 subjects divided into three groups: Group (1): Thirty patients having liver cirrhosis and hepatocellular carcinoma diagnosed by tripahsic CT. Group (2): Thirty liver cirrhosis patients without hepatocellular carcinoma diagnosed by abdominal ultrasound examination. Group (3): Twenty normal subjects (control group) matching in age and sex with patients in groups 1 and 2. Patients will be recruited from the outpatient clinics and inpatient wards of Alexandria Main University Hospital and Medical Research Institute Hospital. Full informed consent will be taken from the patients and approval of the ethical committee of the Faculty of Medicine will be fulfilled. Exclusion criteria: Patients with any inflammatory diseases or other malignancies.

Interventions

DIAGNOSTIC_TESTWRAP53, UCA-1

Diagnostic value of UCA-1 and WRAP53 in HCC

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Any subject without any of the

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic value of long non coding RNA UCA-1 and WRAP53 in Hepatolcellular carcinomaOne yearCalculating sensitivity and specifity of UCA-1 and WRAP53 to assess their diagnostic value in diagnosis of hepatocellular carcinoma

Countries

Egypt

Contacts

Primary ContactAhmed Elsheaita, Msc
A_mohamed200690@alexmed.edu.eg+201062099085

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026